This report on drug abuse testing/screening market studies various test and location types. For decades, drug of abuse test samples were transferred to laboratories with results returned days or even weeks later. More recently, point-of-collection (POC) testing became omnipresent, permitting detection of some drugs and/or their metabolites within minutes of collection. According to market experts, leading countries from North America and Europe are applying drug of abuse tests at several organizational levels such as on the spot drug/alcohol screening, post incident drug/alcohol screening, pre-employment screening, and abstinence monitoring. Government regulations and policies in these countries are assisting the growth of drug abuse testing market mainly through practice of drug testing at workplace.

For the purpose of this study, the global drug abuse testing/screening market on the basis of test type is segmented into urine drug tests, oral fluid drug tests, hair drug tests, blood drug tests, and other drug tests. 

On the basis of location type drug abuse testing/screening market is segmented as on-site screening and laboratory-based screening. Laboratory based tests possess skilled and trained personnel for providing detailed analysis and onsite drugs of abuse testing provide immediate results. 

The drug abuse testing/screening market has been geographically categorized into major regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, Brazil, and GCC countries. 

The major key players profiled in the drug abuse testing/screening market are on the basis of various characteristics such as business description, financial health and budget allocation, product portfolio, and news coverage. The key players profiled in this report are Thermo Fisher Scientific, LabCorp (Laboratory Corporation of America), Abbott Laboratories, Psychemedics Corporation, Sonic Healthcare, Bio-Rad Laboratories, Alere,Inc., F. Hoffman-La Roche, Quest Diagnostics, and Randox Laboratories.

Location Type Segmentation Investigation

In year 2021, the laboratory-based screening segment accounted for the largest market share in the global drug of abusing testing market. One of the key requirements of laboratory-based drug of abuse test location is trained and skilled personnel to provide an accurate result along with in-depth analysis. In laboratory-based screening test, usually the test is reconfirmed using gas chromatography/mass spectrometry or any other advanced techniques to provide accurate results. On the other hand, on-site drug screening test provides accurate results and it is generally preferred for those who take the drug test at home, workplace and educational institutions. 

Test Type Segmentation Analysis

In base year 2021, the urine and oral fluid drug tests collectively attribute the largest share in the market in terms of revenue (USD). According to Quest Diagnostics, Inc., urine drug testing detects recent drug use and is the only testing method approved for federally-mandated testing. End-users seemed to rely on laboratory-based urine testing for its cost-effectiveness and capacity to screen for a wide variety of drug substances. Urine testing was observed as the most common screening method and detects recent use, typically in the previous one to three days. Its application is also apt for all testing reasons – from pre-employment to random to post-accident – and can be performed for a wide range of illicit and prescription drugs. Market experts also suggest that despite market entry of novel solutions and products, lab based urine drug testing is still the gold standard in employee drug testing.  

In base year 2021, North America accounted for the largest share in the global drug of abuse testing/screening market, followed by Asia-Pacific, Europe, LATAM and MEA. The Asia-Pacific region (comprising Japan, China and India as major countries) is anticipated to grow at the fastest CAGR during the forecast period 2016 - 2023. The key factors such as enormous production of illicit drugs, their illegal trade, and increasing consumption have encouraged companies in North America and Europe to conduct drug screening tests such as pre-employment screening, abstinence monitoring, post-incident drug/alcohol screening, and random drug/alcohol screening. The other factors such as government regulations supporting the screening of drug abuse at workplaces have also assisted the growth of drugs of abuse testing market throughout the forecast period.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Drug of Abuse Testing / Screening market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Drug of Abuse Testing / Screening market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Drug of Abuse Testing / Screening market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Drug of Abuse Testing / Screening market?
• Which is the largest regional market for Drug of Abuse Testing / Screening market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Drug of Abuse Testing / Screening market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Drug of Abuse Testing / Screening market worldwide?